Due to its important functions in suppressing cancer growth, invasion and metastasis, and in preventing the cancer death, SIS3 was described in a patent as a novel and effective anti-cancer drug by way of regulating cellular signal transduction mediated by TGF-β/Smad3 in the USA [53]. This evidence concerns the gene TGFB1 and cancer.